Nora Brennan - Jan 3, 2023 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
Executive Vice President and Chief Financial Officer
Signature
/s/ Keith M. McGahan, Attorney-in-Fact for Nora E. Brennan
Stock symbol
SPPI
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 06:49 PM
Previous filing
Jun 23, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +240K +66.63% $0.00 600K Jan 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +840K $0.00 840K Jan 3, 2023 Common Stock 840K $0.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
F2 One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.

Remarks:

Executive Vice President and Chief Financial Officer